Associated Papers
A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report.
Wang D et al.
Bmc Medical Genomics, 2021
Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays.
Sadeghi F et al.
Biological Procedures Online, 2020
Talking Genes in Breast and Pancreatic Malignancies.
Barbara M et al.
Materia Socio-medica, 2019
Cyclin D1 promotes BRCA2-Rad51 interaction by restricting cyclin A/B-dependent BRCA2 phosphorylation.
Chalermrujinanant C et al.
Oncogene, 2016
The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.
Martinez-Useros J et al.
Biomed Research International, 2016
Cancer variation associated with the position of the mutation in the BRCA2 gene.
Lubinski J et al.
Familial Cancer, 2004
Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer.
Real FX et al.
Gut, 2002
BRCA2 and pancreatic cancer.
Naderi A et al.
International Journal of Gastrointestinal Cancer, 2002
BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications.
Goggins M et al.
The American Journal of Pathology, 2000
Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
Goggins M et al.
Cancer Research, 1996
Select a paper to view details